Search by Drug Name or NDC
NDC 00363-0441-01 WAL SOM 25 mg/1 Details
WAL SOM 25 mg/1
WAL SOM is a ORAL TABLET in the HUMAN OTC DRUG category. It is labeled and distributed by Walgreen Company. The primary component is DOXYLAMINE SUCCINATE.
MedlinePlus Drug Summary
Doxylamine is used in the short-term treatment of insomnia (difficulty falling asleep or staying asleep). Doxylamine is also used in combination with decongestants and other medications to relieve sneezing, runny nose, and nasal congestion caused by the common cold. Doxylamine should not be used to cause sleepiness in children. Doxylamine is in a class of medications called antihistamines. It works by blocking the action of histamine, a substance in the body that causes allergic symptoms.
Related Packages: 00363-0441-01Last Updated: 11/30/2022
MedLinePlus Full Drug Details: Doxylamine
Product Information
NDC | 00363-0441 |
---|---|
Product ID | 0363-0441_9cfe1589-c9d7-4076-be2c-27bcbd754b09 |
Associated GPIs | 60300010100310 |
GCN Sequence Number | 003707 |
GCN Sequence Number Description | doxylamine succinate TABLET 25 MG ORAL |
HIC3 | H2E |
HIC3 Description | SEDATIVE-HYPNOTICS,NON-BARBITURATE |
GCN | 11730 |
HICL Sequence Number | 004482 |
HICL Sequence Number Description | DOXYLAMINE SUCCINATE |
Brand/Generic | Generic |
Proprietary Name | WAL SOM |
Proprietary Name Suffix | NIGHTTIME SLEEP AID |
Non-Proprietary Name | Doxylamine succinate |
Product Type | HUMAN OTC DRUG |
Dosage Form | TABLET |
Route | ORAL |
Active Ingredient Strength | 25 |
Active Ingredient Units | mg/1 |
Substance Name | DOXYLAMINE SUCCINATE |
Labeler Name | Walgreen Company |
Pharmaceutical Class | Antihistamine [EPC], Histamine Receptor Antagonists [MoA] |
DEA Schedule | n/a |
Marketing Category | ANDA |
Application Number | ANDA040167 |
Listing Certified Through | 2024-12-31 |
Package
Package Images

NDC 00363-0441-01 (00363044101)
NDC Package Code | 0363-0441-01 |
---|---|
Billing NDC | 00363044101 |
Package | 1 BOTTLE in 1 CARTON (0363-0441-01) / 96 TABLET in 1 BOTTLE |
Marketing Start Date | 2012-09-28 |
NDC Exclude Flag | N |
Pricing Information | N/A |
Standard Product Labeling (SPL)/Prescribing Information SPL b80da99b-d98d-4ff2-a353-192399b84a01 Details
Warnings
Ask doctor before use if you have
- •
- a breathing problem such as asthma, emphysema or chronic bronchitis
- •
- glaucoma
- •
- trouble urinating due to an enlarged prostate gland
Directions
Other information
Inactive ingredients
Principal Display Panel
INGREDIENTS AND APPEARANCE
WAL SOM
NIGHTTIME SLEEP AID
doxylamine succinate tablet |
||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||
|
Labeler - Walgreen Company (008965063) |
Revised: 7/2020
Document Id: 9cfe1589-c9d7-4076-be2c-27bcbd754b09
Set id: b80da99b-d98d-4ff2-a353-192399b84a01
Version: 5
Effective Time: 20200720